Magnetic Resonance (MR) Spectroscopy of Breast Cancer Tissue

HR MAS MR Spectroscopy of Breast Cancer Tissue

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00184210

Enrollment

1000

Registered

2005-09-16

Start date

2000-01-31

Completion date

2020-12-31

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasms

Keywords

Magnetic Resonance Spectroscopy

Brief summary

Breast cancer tissue is collected from women undergoing scheduled surgery for breast cancer. The tissue specimen are analyzed by MR spectroscopy. After MR, the intact tissue specimen can be analyzed by other methods, such as histopathology. The MR spectral profiles are compared to clinical findings such as the patients diagnosis, lymph node status and tumor size.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Palpable breast cancer lesion

Design outcomes

Primary

Measure	Time frame
MRimage of breast cancer tissue	0 hour

Countries

Norway

Outcome results